Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
Palomera
Luis
L
Department of Hematology, University Clinical Hospital, C/ San Juan Bosco, 15 50009 Zaragoza, Spain. hemh@hcu-lblesa.es
Domingo
José Ma
JM
Sola
Carlos
C
Azaceta
Gemma
G
Calvo
María Teresa
MT
Gutierrez
Martin
M
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D017338:Cladribine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D016879:Salvage Therapy; D013156:Splenectomy; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D016898:Interferon-alpha; D017338:Cladribine